# AIoT Health

> AIoT Health is a VC fund in Calgary backing Health Care, mHealth and Health Diagnostics. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Calgary, Canada
- Total investments: 4
- Last investment: Sep 2022
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/aiot-health 
- Website: https://www.aiothealth.ca/

AIoT Health is a method of improving healthcare by understanding how the "average" individual in a cohort responds to treatment. Through the delivery of personalised medicine in the future, nuance will be added to our layer of knowledge. Digital technology and Machine Learning are tools that aid in the implementation of PersonalizedMedicine. Digital technology is powerful in that it can improve healthcare outcomes simply by increasing patient engagement. They are very interested in the ability of biofeedback to improve healthcare outcomes without the need for new procedures or drugs. Portable technology's ability to track longitudinal data points easily opens up new metrics and treatment avenues for continuous improvement in healthcare outcomes.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 100% |
| mHealth | 2 | 50% |
| Health Diagnostics | 2 | 50% |
| Hospital | 1 | 25% |
| Wellness | 1 | 25% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 50% |
| Series A | 1 | 25% |
| Convertible Note | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Canada | 2 | 50% |
| United States | 2 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Arcascope | Arcascope makes apps that utilize algorithms that track circadian rhythms and generates personalized recommendations to help people get their clocks back on track. | $2.9M | Seed | Sep 27, 2022 |  |
| SeamlessMD | Surgery is one of the most vulnerable experiences that a person can ever go through. They find it scary that in the 21st century, they still rely on paper instructions and human memory to get patients through this complicated journey. They can and they must do better.At SeamlessMD, they are on a mission to give every patient the best healthoutcomes after surgery. Together with healthcare providers, they leverage design, data and technology to enhance the patient experience, improve outcomes and lower costs. | $2.9M | Series A | Aug 26, 2020 |  |
| DrugBank | DrugBank augments human intelligence to improve the world’s health. Our suite of products are powered by the world’s most complete and up-to-date pharmaceutical knowledge database. It includes everything there is to know about drugs and how they work in the body. We enable companies to improve healthcare delivery through precision medicine orclinical software applications, as well as uncover insights through data science in drug discovery. Our knowledge base can be integrated into software solutions to help achieve clinical intelligence. Companies can easily scale their usage through our API and launch faster with flexible data modules. By providing users with advanced insights and the right information at the right time, users are empowered to make better health decisions.Our extensive, structured datasets are used to discover novel drug candidates, identify drug repurposing opportunities, and build predictive machine learning models. Companies working with data science can find answers quickly and get drugs to market faster with our evidence-based drug information. Lastly, our publicly available resource, DrugBank Online, is free-to-use with limited datasets available for download for academic and non-commercial researchers. DrugBank has been cited in over 13,000 academic publications and is used by millions of researchers and health professionals globally. | $92.5K | Seed | Jul 15, 2020 |  |
| Alio | “Smart” wearables and implantables for dialysis and cardiovascular disease patients that transfer clinically actionable data from the device directly into the clinician’s EHR system. |  | Convertible Note | Feb 01, 2020 |  |

4 of 4 investments shown.

## Co-investors
- [Accelerate Blue Fund](https://shizune.co/investors/profile/accelerate-blue-fund) — VC Fund, 1 deal together
- [Accelerate Fund](https://shizune.co/investors/profile/accelerate-fund) — VC Fund, 1 deal together
- [Anges Quebec](https://shizune.co/investors/profile/anges-quebec) — VC Fund, 1 deal together
- [Bluesky Equities](https://shizune.co/investors/profile/bluesky-equities-ltd) — VC Fund, 1 deal together
- [BoxOne Ventures](https://shizune.co/investors/profile/boxone-ventures) — VC Fund, 1 deal together
- [HealthX Ventures](https://shizune.co/investors/profile/healthxventures) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does AIoT Health invest in?

AIoT Health invests primarily in Health Care, mHealth and Health Diagnostics startups, most often at Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did AIoT Health last invest?

The most recent investment recorded for AIoT Health closed in Sep 2022. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co